Skip to main content

Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin

    Basic Details
    Date Posted
    Thursday, January 23, 2020
    Status
    Complete
    Medical Product
    atorvastatin
    rosuvastatin
    ticagrelor
    Description

    In this report we evaluated concurrent use of ticagrelor (all strength, 60mg, and 90mg) with atorvastatin or rosuvastatin in the Sentinel Distributed Database (SDD).

    The study period included data from January 1, 2012 to June 30, 2018. We distributed this request to 17 Data Partners on January 8, 2019.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2012 - June 30, 2018
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)